2012
DOI: 10.1093/jpepsy/jss050
|View full text |Cite
|
Sign up to set email alerts
|

Does the Brief Symptom Inventory-18 Case Rule Apply in Adult Survivors of Childhood Cancer?: Comparison With the Symptom Checklist-90

Abstract: The BSI-18 is a useful measure for evaluating distress in adult survivors of childhood cancers; however, the standard BSI-18 case-rule has not been validated for this population, and an alternative case rule should be considered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
50
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(51 citation statements)
references
References 49 publications
1
50
0
Order By: Relevance
“…This case rule was originally developed for the SCL-90-R and subsequently recommended for the BSI and BSI-18, though the manual does not present any empirical support for the case-rule as applied to the BSI-18. Following common practice for the BSI (e.g., Brown, Whiteley, Harper, Nichols, & Nieves, 2015; Endermann, 2005) users of the BSI-18 in oncology (Merport & Recklitis, 2012; Michel et al, 2010; Zabora et al, 2001; Zeltzer et al, 2009) and other populations (Hart et al, 2014; Hopp, Anderson, Krumholz, Gruber-Baldini, & Shulman, 2012; Mustanski, Garofalo, Herrick, & Donenberg, 2007; Petkus et al, 2010) commonly define overall significant symptoms on the BSI-18 using the GSI scale alone, classifying respondent with GSI t-score ≥ 63 as having clinically significant symptoms. Both the published BSI-18 case-rule criteria (t-score score ≥ 63 on the GSI, or any two of symptom scales) and the conventional case-rule of GSI t-score ≥ 63 were evaluated in this study.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…This case rule was originally developed for the SCL-90-R and subsequently recommended for the BSI and BSI-18, though the manual does not present any empirical support for the case-rule as applied to the BSI-18. Following common practice for the BSI (e.g., Brown, Whiteley, Harper, Nichols, & Nieves, 2015; Endermann, 2005) users of the BSI-18 in oncology (Merport & Recklitis, 2012; Michel et al, 2010; Zabora et al, 2001; Zeltzer et al, 2009) and other populations (Hart et al, 2014; Hopp, Anderson, Krumholz, Gruber-Baldini, & Shulman, 2012; Mustanski, Garofalo, Herrick, & Donenberg, 2007; Petkus et al, 2010) commonly define overall significant symptoms on the BSI-18 using the GSI scale alone, classifying respondent with GSI t-score ≥ 63 as having clinically significant symptoms. Both the published BSI-18 case-rule criteria (t-score score ≥ 63 on the GSI, or any two of symptom scales) and the conventional case-rule of GSI t-score ≥ 63 were evaluated in this study.…”
Section: Methodsmentioning
confidence: 99%
“…Both the published BSI-18 case-rule criteria (t-score score ≥ 63 on the GSI, or any two of symptom scales) and the conventional case-rule of GSI t-score ≥ 63 were evaluated in this study. In addition, two alternative BSI-18 case rules, the GSI t-score ≥ 57 cut-off reported in a study of cancer patients (Zabora et al, 2001) and the GSI t-score ≥ 50 cut-off recommended in two studies of YACS (Merport & Recklitis, 2012; Recklitis & Rodriguez, 2007) and a study of elderly medical patients (Petkus et al, 2010) were also evaluated.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…After screening titles and abstracts, we excluded 108, and after screening the full texts, we excluded an additional 23 articles. We extracted the information of screening from eight articles, of which six were studies done in a US group around Christopher Recklitis [23-25, 26 && , 27,28], one in the United Kingdom [29] and one in Australia [30]. In 2014, only one study was published [26 && ].…”
Section: Resultsmentioning
confidence: 99%
“…In a second study in 2012, both questionnaires were thus administered separately [28]: the SCL-90-R was completed on paper in a larger pack of research questionnaires, whereas the BSI-18 was completed on a handheld patient assessment device. Among the 193 adult survivors of various cancers, 31 (16.1%) were identified as cases in the SCL-90-R. Again, the adapted case rule for the BSI-18 (T !…”
Section: Resultsmentioning
confidence: 99%